Back to CGEM

Lynx1 Capital Management LP → CGEM

Lynx1 Capital Management LP CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$137.6M
Q3 2026
Peak value
$163.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$92.8M
Q1 2026$127.4M
Q2 2026$163.2M
Q2 2026$163.2M
Q3 2026$137.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$137.6M8.96M——
Q2 2026$163.2M8.96M——
Q2 2026$163.2M8.96M——
Q1 2026$127.4M8.96M——
Q4 2025$92.8M8.96M——

Other funds holding CGEM

Other Lynx1 Capital Management LP positions

GHRS

GH RESEARCH PLC

$356.5M
GHRS

GH RESEARCH PLC

$311.4M
STOK

STOKE THERAPEUTICS INC

$171.5M
STOK

STOKE THERAPEUTICS INC

$155.1M
GHRS

GH RESEARCH PLC

$151.3M
GHRS

GH RESEARCH PLC

$132.2M
STOK

STOKE THERAPEUTICS INC

$132.1M
STOK

STOKE THERAPEUTICS INC

$132.1M